Prosetta Bioconformatics is a biotech/pharma research firm focused on discovering and developing novel small-molecule drugs for treating viral and bacterial infections, cancers, and neurodegenerative diseases. One of the key drugs in the pipeline is for community and hospital-acquired infections of antimicrobial-resistant (AMR) superbugs.